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Symptoms referable to irritation and inflammation of the pharynx, larynx and 
bronchi are very common in the community. Hoarseness, persistent sore throat, 
globus and chronic cough are present in up to 25% of the primary care 
population and account for a large number of referrals to gastroenterologists, 
respiratory physicians and ear, nose and throat (ENT) specialists.1 
Epidemiological research has documented an association between gastro-
esophageal reflux disease (GERD) and a range of “supra-esophageal” symptoms 
and diseases (Table 1). Further clinical studies report a high prevalence of typical 
reflux symptoms in patients with signs of laryngo-pharyngeal disease 2 and, also, 
a high frequency of throat and respiratory symptoms among patients with 
pathological esophageal acid exposure.3 Based on this evidence, the Montreal 
classification included so called laryngo-pharyngeal or supra-esophageal reflux 
disease (SERD) as a subcategory of GERD,4 and clinical reviews have proposed 
gastric acid and reflux suppression as empirical treatment for these “atypical” 
manifestations of GERD.5 Notwithstanding this broad based agreement, if reflux 
of gastric contents is a common cause of supra-esophageal symptoms and 
disease, then many issues remain unresolved. In many cases the mechanism of 
disease is a riddle. The inability of current investigations to establish an 
association between reflux events and symptoms is a mystery. The failure of 
proton pump inhibitors (PPI) to treat laryngo-pharyngeal symptoms or heal 
mucosal disease in well-designed clinical trials is an enigma. In this issue of 
Gastroenterology, Babaei and colleagues applied state-of-the-art physiological 
measurements to study the pharyngo-esophageal response to simulated reflux 
events.6 Their findings identified specific abnormalities in patients with symptoms 
suggestive of SERD. Moreover their approach to investigation could point the 
way to promising new clinical diagnostic tests for this condition. 
Mechanism of disease 
The simplest mechanism proposed for SERD is microaspiration of gastric 
contents into the pharynx and larynx.7 In vivo experiments suggest that minute 
amounts of acid are sufficient to cause mucosal damage, especially in the 
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presence of pepsin.8 However, in most cases, ambulatory pH-impedance 
monitoring detects very few pharyngeal reflux events and this direct mechanism 
alone cannot explain the frequent symptoms reported by many patients. Other 
proposals include the possibility that distal esophageal reflux causes laryngo-
pharyngeal symptoms by an indirect mechanism either by triggering an 
antedromic vasovagal reflex and neurogenic inflammation, or by prompting 
repetitive swallowing behavior.7 An additional consideration is that acid exposure 
to the distal esophagus heightens visceral sensitivity of the whole organ through 
a central mechanism.9 If this effect extends to the larynx and pharynx, then this 
would lower the sensory threshold not only to further reflux events but also to a 
range of other potential stimuli such as temperature change, cigarette smoke, 
airborne allergens and ingestion of alcohol or other irritants.7   
Physiological Measurement 
In patients with heartburn, acid regurgitation and reflux esophagitis the cause of 
laryngo-pharyngeal symptoms and disease may be obvious. However, the 
majority of patients with suspected SERD do not have typical reflux symptoms or 
mucosal disease.10 In this group, physiological measurements that detect reflux 
events at, or close to, the site of pathology provide objective evidence to support 
of the diagnosis. Studies that include pharyngeal pH sensors in addition to 
esophageal sensors may be more discriminatory of SERD patients.11 The current 
standard is ambulatory pH-impedance reflux monitoring.12 This technology can 
detect both acid and non-acid reflux and, in principle, establish a causal 
association between these events and symptoms. Unfortunately, there is little 
consensus regarding the optimal acquisition, analysis or interpretation of this 
data. Moreover, in practice, if isolated pharyngeal reflux events are sufficient to 
cause disease, if symptoms are present all the time, or if there is only an indirect 
link between reflux and symptoms, then even the most accurate ambulatory 
reflux monitoring will not establish a definitive SERD diagnosis. These issues are 
compounded by the fact that symptoms such as hoarseness and chronic cough 
are very common and have multiple potential causes that may coexist with 
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GERD by chance. These are real and important concerns because treatment 
decisions, including referral for anti-reflux surgery, are based on this information. 
Given the limitations of existing tests, new methods to detect SERD are of 
interest. Measurement of pepsin and bile acids in the saliva have been proposed 
as an 'office-based' method for detecting reflux. Recent studies indicate that high 
levels of pepsin provide a specific marker of GERD.13 The presence of this 
gastric enzyme in the throat can be explained only by supra-esophageal reflux 
and, therefore, this approach may be particularly value for SERD diagnosis.14 
The same concept can be applied by nuclear imaging. Scintigraphy is used to 
detect reflux to the pharynx after ingestion of a radio-labelled drink, with late 
studies of the lungs obtained to detect aspiration.15 Both these investigations are 
well-tolerated and require less expertise to interpret than pH-impedance studies; 
however, neither provides insight into the mechanism of disease.   
To address this issue, the current study applied high-resolution impedance 
manometry (HRiM) to obtain a detailed description of sensory-motor mechanisms 
that control upper esophageal sphincter (UES) function and how this is disrupted 
in patients with typical symptoms of GERD and SERD.6 It is known from the 
previous work by Reza Shaker’s group,16 that both relaxation and contractile 
UES responses are present in health, each governed by independent neural 
circuits that are activated in relation to the rate, magnitude and physical 
properties of distending stimuli. Relaxation enables venting of gas (“belching”). 
Contraction guards against reflux of gastric contents into the pharynx. The 
authors identified the UES relaxation reflex (RR) and contraction reflex (CR) by 
HRM and SER events using impedance data. These observations revealed that 
some patients with SERD symptoms have aberrant UES responses to rapid 
esophageal infusion of liquid (i.e. simulated reflux) that were not seen in patients 
with GERD symptoms or healthy controls. Specifically, rather than an effective 
contraction of the UES and proximal esophagus to clear “refluxate” away from 
the sensitive laryngo-pharyngeal region, some patients had an inappropriate 
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UESRR and / or ineffective UES and esophageal CR during liquid reflux. The 
absolute frequency of SER during individual studies and how often SER was 
associated with each form of dysfunction was not reported and therefore the 
overall extent to which these aberrant responses are permissive of reflux is 
unknown; nevertheless, the unique abnormality in patients with SERD symptoms 
were inappropriate UESRRs. Although failure to initiate UES and esophageal CR 
also occurred in this group, the latter abnormality was seen also in GERD, and 
SER was never reported following “isolated” failure of the protective response.  
This study provides new insight into the pathophysiology of SERD. The presence 
of inappropriate UESRR in patients with laryngo-pharyngeal symptoms is 
consistent with microaspiration as a mechanism of disease. In addition, the 
technology and methodology used by this group is of interest to clinicians looking 
for a new, more informative diagnostic test for SERD. HRiM provides a 
comprehensive, non-radiological assessment of pharyngo-esophageal function. 
High resolution manometry with spatiotemporal “Clouse” plots delivers a 
continuous representation of motor activity from the pharynx to the stomach. 
Intraluminal impedance detects bolus movement by measuring changes in 
resistance between multiple pairs of electrodes. To date, this combined 
technology has been applied most often to study patients with pharyngeal 
swallowing problems and to assess the risk of aspiration.17 The findings reported 
here suggest that HRiM could be applied also to assess the risk of supra-
esophageal reflux in patients with laryngo-pharyngeal symptoms. Importantly, the 
HRiM methodology is different to ambulatory pH-impedance monitoring or 
stationary observations after a test meal because, rather than relying on the 
detection of spontaneous SER events, a standardized challenge designed to 
simulate gastro-esophageal reflux (i.e. esophageal infusion) is applied to identify 
patients at risk of SERD.   
Further validation is required before HRiM could be used for SERD diagnosis. 
Surprisingly, the current study did not apply standardized questionnaires, 
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laryngoscopic assessment or physiological studies to define study groups. Not 
one of these investigations represents a “gold standard"; however, symptoms are 
non-specific and the differential diagnosis for patients with “troublesome 
regurgitation along with at least one supra-esophageal manifestation” (the entry 
criterion used in the study) includes motility disorders, rumination syndrome and 
a number of ENT or respiratory diseases.18 This could explain why only 5/19 
patients with “typical” SERD symptoms had the “characteristic” UESRR 
abnormality after rapid esophageal saline infusion. Future studies should apply 
standardized inclusion criteria with either pathological acid exposure or a positive 
reflux-symptom association on pH-impedance monitoring. Additionally, HRiM 
data analysis could be optimized. In this paper assessment of impedance was 
subjective and considered separately to the pressure measurements. Pressure 
Flow Analysis (PFA) is a semi-automated method which integrates high 
resolution pressure and impedance signals to obtain objective metrics that 
cannot be determined by either method alone.19 Application of PFA in patients 
with pharyngeal dysfunction identifies biomechanical factors that determine the 
success or failure of the swallow and defines the risk of aspiration.19, 20 This 
includes not only UES relaxation, but also UES opening and the efficacy of 
pharyngeal clearance.20 Adapting this approach, UES responses to esophageal 
infusion could be quantified in terms of “flow permissive characteristics” to detect 
factors that determine the risk of supra-esophageal reflux.  
The success of scientific medicine is based on the identification and treatment of 
the pathophysiological basis of disease. To date, the diagnosis of SERD has 
been based as much on subjective assessment as objective physiology. Now, as 
with the introduction of HRM and the Chicago Classification of esophageal 
motility disorders a few years ago, new technology and methods is driving 
progress in the pharyngo-esophageal region. HRiM combined with analysis that 
utilizes all the information acquired, are now available to describe the causes of 
SERD, identify individual patients that can benefit from anti-reflux treatment and, 
in the process, solve this riddle wrapped in a mystery inside an enigma.  
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Table 1 
Extraesophageal conditions linked to SERD 
Symptoms Diseases 
 Acid Regurgitation ▪ Dental erosions
 Voice change ▪ Sinusitis
 Hoarseness ▪ Posterior Laryngitis
 Chronic sore throat ▪ Vocal cord ulceration
 Repetitive throat clearing ▪ Laryngeal polyps
 Globus sensation ▪ Cancer of pharynx / larynx
 Chronic cough ▪ Bronchiectasis
 Recurrent aspiration ▪ Non-atopic asthma
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